{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:19:56Z","timestamp":1765232396759},"reference-count":24,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuklearmedizin"],"published-print":{"date-parts":[[2017]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Purpose: Medical imaging plays an important role in selecting patients with metastatic castration-resistant prostate cancer for 223Ra- dichloride therapy of bone metastases. The purpose of this study was to investigate whether 68Ga-PSMA-PET has incremental value over conventional imaging for selecting patients suitable for 223Ra-dichloride therapy. Methods: In 27 consecutive patients referred for 223Ra-dichloride therapy additional 68Ga-PSMA-PET\/CT was performed and tracer distribution was evaluated systematically with respect to the detection of visceral metastases and bone metastases with inadequate uptake on bone scintigraphy. Results: In 4 patients (15 %) 68Ga- PSMA-PET revealed previously unknown visceral metastases (3 liver, 1 adrenal gland), which changed the therapeutic decision in 2 cases. PET revealed more extended tumour involvement in the bone compared to bone scintigraphy in 9 patients (33 %). In 3 of these, the mismatch was extensive enough to question suitability for 223Ra-dichloride therapy. Conclusions: Additional 68Ga-PSMA-PET as a gatekeeper between conventional staging and 223Ra-dichloride therapy can provide valuable additional information with regard to visceral metastases and tumour manifestations without adequate bone mineral turnover. It may lead to a change in therapeutic management in a significant number of patients and should therefore be considered in future clinical trials.<\/jats:p>","DOI":"10.3413\/nukmed-0846-16-09","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T08:21:28Z","timestamp":1484122888000},"page":"14-22","source":"Crossref","is-referenced-by-count":31,"title":["Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma"],"prefix":"10.3413","volume":"56","author":[{"given":"Kambiz","family":"Rahbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Konnert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"B\u00f6gemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Stegger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Br\u00e4uer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"10.3413\/Nukmed-0846-16-09-1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.170720"},{"key":"10.3413\/Nukmed-0846-16-09-2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2069-0"},{"key":"10.3413\/Nukmed-0846-16-09-3","doi-asserted-by":"crossref","unstructured":"Ahmadzadehfar H, Azgomi K, Hauser S et al.68Ga-PSMA-11 PET as a gate-keeper for the treatment of metastatic prostate cancer with radium-223: proof of concept. J Nucl Med 2016; DOI: jnumed.116.178533 (Epub ahead of print)","DOI":"10.2967\/jnumed.116.178533"},{"key":"10.3413\/Nukmed-0846-16-09-4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2016.08.003"},{"key":"10.3413\/Nukmed-0846-16-09-5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2016.01.012"},{"key":"10.3413\/Nukmed-0846-16-09-6","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001374"},{"key":"10.3413\/Nukmed-0846-16-09-7","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-62-736-318"},{"key":"10.3413\/Nukmed-0846-16-09-8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.154153"},{"issue":"3","key":"10.3413\/Nukmed-0846-16-09-9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-0037-1616480","volume":"55","author":"Fendler","year":"2016","journal-title":"Nuklearmedizin"},{"key":"10.3413\/Nukmed-0846-16-09-10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/030089161109700515","volume":"97","author":"Giovanella","year":"2011","journal-title":"Tumori"},{"key":"10.3413\/Nukmed-0846-16-09-11","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e3282f8140c"},{"key":"10.3413\/Nukmed-0846-16-09-12","unstructured":"itG. Ga-68 Radiolabeling KIT, Operating Manual, Version 1.0, Status 01\/2014, itG, Garching, Germany, 2014"},{"key":"10.3413\/Nukmed-0846-16-09-13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/028418518702800525","volume":"28","author":"Lantto","year":"1987","journal-title":"Acta Radiol"},{"key":"10.3413\/Nukmed-0846-16-09-14","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v7.i8.202"},{"key":"10.3413\/Nukmed-0846-16-09-15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213755"},{"key":"10.3413\/Nukmed-0846-16-09-16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3366-9"},{"key":"10.3413\/Nukmed-0846-16-09-17","doi-asserted-by":"crossref","unstructured":"Rahbar K, Ahmadzadehfar H, Kratochwil C et al. German multicenter study investigating177Lu-PSMA-617 radioligand therapy in advanced prostate cancer patients. J Nucl Med 2016; DOI: jnumed.116.183194 (Epub ahead of print)","DOI":"10.2967\/jnumed.116.183194"},{"key":"10.3413\/Nukmed-0846-16-09-18","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001240"},{"key":"10.3413\/Nukmed-0846-16-09-19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.173757"},{"key":"10.3413\/Nukmed-0846-16-09-20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.169243"},{"key":"10.3413\/Nukmed-0846-16-09-21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.156026"},{"key":"10.3413\/Nukmed-0846-16-09-22","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70183-4"},{"key":"10.3413\/Nukmed-0846-16-09-23","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21262"},{"key":"10.3413\/Nukmed-0846-16-09-24","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-013-0749-x"}],"container-title":["Nuklearmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.3413\/Nukmed-0846-16-09.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T07:24:18Z","timestamp":1658388258000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.3413\/Nukmed-0846-16-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":24,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2018,1,2]]},"published-print":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.3413\/nukmed-0846-16-09","relation":{},"ISSN":["0029-5566","2567-6407"],"issn-type":[{"value":"0029-5566","type":"print"},{"value":"2567-6407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}